Managing mental and emotional health is a key part of managing chronic kidney disease.
Discusses Positive Interim Results From JADE101 Phase I Healthy Volunteer Study and Development Plans June 1, 2026 8:00 ...
Objectives Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) are associated with improved ...
Hansa Biopharma AB, "Hansa" , today announced positive topline results from the European 20-HMedIdeS-19 Post Authorization Efficacy Study (PAES), an open-label confirmatory study investigating ...
Background Artificial intelligence ECG (AI-ECG) models can predict cardiovascular outcomes, but their clinical adoption is limited by restricted access to training data and uncertain generalisability.
A survey found that clinicians are not discussing genetic testing with 80% of patients with kidney disease who meet ...
The 2026 SNMMI annual meeting featured a clinical diagnosis and therapy session and a presentation by Dr. Kiflom Gebreslassea discussing a longitudinal analysis of estimated glomerular filtration rate ...
In a new study, researchers found low glomerular filtration rate and chronic histologic damage predicted eGFR loss in people ...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran ...
From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart ...
The FDA has granted Priority Review to finerenone (Kerendia) for adults with type 1 diabetes and CKD, following FINE-ONE trial data showing a 25% reduction in UACR.
aDepartment of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA bDepartment of Epidemiology and Biostatistics, University of California San Francisco, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results